scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-3476(96)70084-7 |
P698 | PubMed publication ID | 8804341 |
P50 | author | Miguel Reyes-Múgica | Q90616688 |
Sudha Iyengar | Q64008607 | ||
P2093 | author name string | C Smith | |
K K Kidd | |||
M S Keller | |||
M Genel | |||
R J Touloukian | |||
J R Gill | |||
M Reyes-Múgica | |||
P2860 | cites work | Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A | Q72690857 |
Medullary thyroid carcinoma, genes, and the prevention of cancer | Q72690860 | ||
Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A | Q72692491 | ||
The practical management of multiple endocrine neoplasia | Q81066569 | ||
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. | Q34334980 | ||
Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. | Q41202102 | ||
Presymptomatic testing using DNA markers for individuals at risk for familial multiple endocrine neoplasia 2A. | Q42020687 | ||
Medullary carcinoma in children. Results of early detection and surgery | Q42498682 | ||
Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa. | Q42504153 | ||
Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children | Q43579554 | ||
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. | Q48114164 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
medullary carcinoma | Q6807316 | ||
P304 | page(s) | 459-464 | |
P577 | publication date | 1996-09-01 | |
P1433 | published in | The Journal of Pediatrics | Q7743611 |
P1476 | title | Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy | |
P478 | volume | 129 |
Q37023603 | A differential diagnosis of inherited endocrine tumors and their tumor counterparts |
Q36004168 | Endocrine tumor syndromes in infancy and childhood |
Q33706700 | Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study |
Q78254404 | Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children |
Q36799232 | Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma |
Q79171876 | Lessons Learned from the Management of a Rare Genetic Cancer |
Q36170027 | Management of thyroid cancers |
Q33591999 | Medullary thyroid cancer: monitoring and therapy |
Q48675067 | Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations |
Q33533942 | Multiple endocrine neoplasia type 2A: a 25-year review |
Q34511708 | Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation |
Q34522459 | Multiple endocrine neoplasia type 2a (MEN2a): a call for psycho-social research |
Q54773654 | Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. |
Q36153645 | Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2: Retrospective Cohort Analysis |
Q77424594 | Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children |
Q42527943 | Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing |
Q28709562 | RET gene abnormalities and thyroid disease: who should be screened and when |
Q36004174 | The pathology of preclinical medullary thyroid carcinoma |
Q43921039 | Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers |
Search more.